Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab and Infliximab Induction Followed by Sirolimus or Tacrolimus in Kidney Transplant
NCT02711202Completed
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Jan 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of sirolimus in kidney transplant rejection (2 arms), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoints: Number of Patients Alive at 1 year and Number of Patients With Functional Graft at 1 year. Started Jan 2007; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02711202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02711202.